NovaBay Pharmaceuticals I...

AMEX: NBY · Real-Time Price · USD
0.59
-0.01 (-1.17%)
At close: Jun 05, 2025, 3:59 PM
0.60
1.79%
Pre-market: Jun 06, 2025, 08:46 AM EDT
-1.17%
Bid 0.59
Market Cap 3.46M
Revenue (ttm) 7.15M
Net Income (ttm) 3.66M
EPS (ttm) 24.38
PE Ratio (ttm) 0.02
Forward PE -1.57
Analyst Buy
Ask 0.65
Volume 34,512
Avg. Volume (20D) 49,753
Open 0.58
Previous Close 0.60
Day's Range 0.58 - 0.61
52-Week Range 0.36 - 3.15
Beta 0.41

About NBY

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol NBY
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for NBY stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts
7 months ago
+18.24%
NovaBay Pharmaceuticals shares are trading higher ... Unlock content with Pro Subscription
8 months ago
+48.92%
NovaBay Pharmaceuticals shares are trading higher after the company announced it reached a definitive deal to sell its Avenova assets for $9.5 million.